In 2021, operating income from these PBMs' affiliated pharmacies from specialty generics totaled 12% of all operating income for the parent corporations' business segments. The Big 3 PBMs are ...

The agency’s report found that the “Big 3 PBMs” – CVS Health’s (CVS) Caremark Rx, UnitedHealth’s (UNH) OptumRx, and Cigna’s (CI) Express Scripts – marked up “numerous specialty ...

The report found that these “Big 3” pharmacy benefit managers (PBMs) in the U.S. pocketed about $7.3 billion in excess revenue between 2017 and 2022 by marking up certain medicines by ...

Discover how the three largest pharmacy benefit managers are rejecting biosimilars from their formularies, except for their own private-label drugs.

The investigation revealed the three biggest PBMs undertook a variety of actions that boosted their earnings but increased costs for plan sponsors, taxpayers and patients, according to the FTC.

The three biggest PBM-owned pharmacies charged ... The new report is a sequel to a report, released in July, that accused big PBMs of paying their own pharmacies more for drugs than they paid ...

Douglas Hoey, RPh, MBA, a pharmacist and CEO of the National Community Pharmacists Association, criticized the PBMs for their "wild profiteering and self-dealing." "While the Big 3 have ...

The "Big 3" PBMs also separately generated an estimated $1.4 billion of income from spread pricing, FTC finds. Jeff Lagasse, Editor A complete guide to lease accounting for healthcare organizations ...